Department of Diagnostic and Interventional Radiology, ''Maggiore della Carita`''Hospital, University of Eastern Piedmont ''Amedeo Avogadro'', C.so Mazzini 18, 28100, Novara, NO, Italy,
Radiol Med. 2015 May;120(5):440-8. doi: 10.1007/s11547-014-0468-y. Epub 2014 Oct 28.
This paper reviews our experience in endovascular treatment of isolated iliac artery aneurysms (IIAAs) with a large number of patients.
From May 2005 to September 2013, 45 patients (43 men and two women; mean age, 74 ± 10 years) with a total of 59 IIAAs underwent endovascular treatment at our institute. We evaluated technical success, long-term patency, early and late complications and overall mortality. Patients were divided into two groups: emergency-treatment group and elective-treatment group.
At a median follow-up of 34.3 months, we achieved a technical success of 97.8 %, a primary patency of 95.5 % and a secondary patency of 100 %, with complete exclusion of the aneurysm in 84.5 % of cases. The incidence of endoleaks was of 15.5 %: eight were type II and one was type III; perioperative mortality was 4.7 %.
Our study documents the effectiveness, in both emergency and elective settings, of the endovascular treatment of iliac aneurysms (EVIAR), which has become the first-choice treatment at our institute. In particular cases, it is also possible to avoid embolisation of the internal iliac artery.
本文回顾了我们在大量患者中采用血管内治疗孤立性髂动脉动脉瘤(IIAA)的经验。
2005 年 5 月至 2013 年 9 月,我院对 45 例(43 名男性和 2 名女性;平均年龄 74±10 岁)共 59 个 IIAA 患者进行了血管内治疗。我们评估了技术成功率、长期通畅率、早期和晚期并发症及总体死亡率。患者分为急诊治疗组和择期治疗组。
在中位数为 34.3 个月的随访中,我们获得了 97.8%的技术成功率、95.5%的一期通畅率和 100%的二期通畅率,84.5%的病例完全隔绝了动脉瘤。内漏的发生率为 15.5%:8 例为 II 型,1 例为 III 型;围手术期死亡率为 4.7%。
我们的研究证明了血管内治疗髂动脉瘤(EVIAR)在急诊和择期治疗中的有效性,这已成为我院的首选治疗方法。在特殊情况下,还可以避免对内髂动脉的栓塞。